ImmunityBio, Inc.
IBRX
$7.77
-$0.29-3.60%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -992.36M | -854.53M | -351.40M | -348.62M | -367.09M |
| Total Depreciation and Amortization | 16.50M | 15.98M | 15.43M | 15.80M | 16.30M |
| Total Amortization of Deferred Charges | 100.00K | 100.00K | 100.00K | 5.01M | 11.21M |
| Total Other Non-Cash Items | 722.27M | 576.86M | 85.27M | 58.87M | 38.51M |
| Change in Net Operating Assets | -27.65M | -32.79M | -54.33M | -50.76M | -48.48M |
| Cash from Operations | -281.14M | -294.39M | -304.94M | -319.70M | -349.56M |
| Capital Expenditure | -6.94M | -4.50M | -3.85M | -5.05M | -7.11M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -269.97M | -181.08M | -145.96M | -178.49M | 69.96M |
| Cash from Investing | -276.91M | -185.58M | -149.80M | -183.54M | 62.85M |
| Total Debt Issued | 77.89M | 77.95M | 2.88M | 0.00 | 0.00 |
| Total Debt Repaid | -2.94M | -2.04M | -1.16M | -16.00K | -26.00K |
| Issuance of Common Stock | 429.88M | 557.30M | 400.78M | 454.77M | 296.99M |
| Repurchase of Common Stock | -8.05M | -8.06M | -2.27M | -2.48M | -2.63M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 496.78M | 625.15M | 400.24M | 452.28M | 294.34M |
| Foreign Exchange rate Adjustments | 68.00K | 147.00K | 15.00K | 3.00K | 70.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -61.20M | 145.33M | -54.48M | -50.96M | 7.70M |